US NeuroSurgical Holdings Inc
For the period ended Dec 31, 2023. Filed Apr 5, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 5, 2024
EHSIStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Item 8. | Financial Statements and Supplementary Data. |
|---|
The financial statements and supplementary data required by this item are set forth in this Annual Report on Form 10-K beginning at page 31.
Contents
| Page | ||
|---|---|---|
| Consolidated Financial Statements | 31 | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 3233) | 32 | |
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | 33 | |
| Consolidated Statements of Operations for the years ended December 31, 2023 and 2022 | 34 | |
| Consolidated Statements of Equity for the years ended December 31, 2023 and 2022 | 35 | |
| Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022 | 36 | |
| Notes to Consolidated Financial Statements | 37 | |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.